Clinical trial Recruiting at 1 site Interventional Ages 12 to 17

Non-invasive vagus nerve stimulation paired with arm rehab for teens with spastic cerebral palsy

Official title: Use of Paired Non-Invasive Vagus Nerve Stimulation in Rehabilitation of Adolescents With Cerebral Palsy: An Open Label Safety Feasibility Trial

Run by Icahn School of Medicine at Mount Sinai · NCT07394608 · Data updated 2026-11-12

This trial tests non-invasive vagus nerve stimulation paired with upper-extremity rehabilitation to see if it safely improves arm and hand function in adolescents (12–17) with spastic cerebral palsy.

More Cerebral Palsy trials

Quick facts

Study typeInterventional
Ages12 Years to 17 Years
SexAll
Enrollment10 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedMay 26, 2026
Main results expectedMarch 1, 2028
Study endsMarch 1, 2028
Registry record updatedOctober 28, 2026
Trial IDNCT07394608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 12–17 with spastic cerebral palsy, GMFCS level II–III, measurable hand impairment (Jebsen Taylor Hand Function Test score under 37.08), who can follow two-step commands and give assent.

Probably not a fit

Patients outside the 12–17 age range, those without spastic cerebral palsy or with GMFCS levels outside II–III, individuals with prior vagus nerve injury or implanted electrical devices, or those unable to follow commands or provide assent are unlikely to benefit from or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This open-label safety and feasibility study delivers non-invasive transauricular vagus nerve stimulation (taVNS) paired with upper-extremity therapy to adolescent participants with spastic cerebral palsy. Participants are screened for age (12–17), GMFCS level II–III, and a Jebsen Taylor Hand Function Test score under 37.08 on the affected side, and must be able to follow two-step commands and provide assent. The protocol combines taVNS sessions with task-specific motor training and monitors safety, tolerability, and preliminary changes in motor impairment. The single-site study is conducted at the Charles Lazarus Children's Abilities Center at Mount Sinai in New York City and is not blinded or randomized.

Why it matters

Potential benefit: If successful, this approach could increase gains from arm and hand rehabilitation and improve functional use of the affected limb in adolescents with spastic cerebral palsy.

How similar studies have gone: Small studies pairing invasive or non-invasive VNS with rehabilitation in adults (for example after stroke) have shown promising motor gains, but paired taVNS in adolescent cerebral palsy remains relatively novel and not yet widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

* Age 12-17 years old
* Diagnosis of spastic cerebral palsy
* Gross Motor Function Classification System (GMFCS) Level II-III (will be evaluated at screening)
* Jebsen Taylor Hand Function Test Score of \<37.08 on the affected side at time of screening visit (will be evaluated at screening)
* Ability to communicate and follow two step commands at the time of screening
* Ability to provide assent as detailed in consent form and based on assessment using the University of California, San Diego Brief Assessment of Capacity to Consent

Exclusion criteria:

* Previous vagus nerve injury
* Less than 12 years old or greater than 18 years old
* History of left or bilateral vagotomy
* Current use of other implanted stimulation devices including but not limited to pacemaker, deep brain stimulator, implanted vagus nerve stimulators, cochlear implants, implantable cardiac defibrillators (ICDs)etc.
* Current use of any investigational devices or investigational drugs not otherwise specified - Past Medical History for any of the following:

  * Acute suicidal thinking or behavior
  * History of schizophrenia, schizoaffective disorder, or delusional disorders
  * History of rapid cycling bipolar disorder
  * Progressive neurological diseases
  * Cardiac arrhythmias or other abnormalities
  * History of dysautonomia including but not limited to orthostatic hypotension, postural orthostatic tachycardia syndrome, vasovagal syncope etc.
* GMFCS score of less than II or greater than III (will be evaluated at screening)
* Jebsen Taylor Hand Function Test Score of \>37.08 on the affected side at time of screening visit (will be evaluated at screening)

Where it's running

  • The Charles Lazarus Children's Abilities Center
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: David Putrino, PhD — Icahn School of Medicine at Mount Sinai
  • Study coordinator: Jenna Tosto Mancuso, PT, DPT,NCS
  • Email: jenna.tosto@mountsinai.org
  • Phone: 212-241-8454

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.